GB0222787D0 - Metastasis inducing compounds - Google Patents
Metastasis inducing compoundsInfo
- Publication number
- GB0222787D0 GB0222787D0 GBGB0222787.4A GB0222787A GB0222787D0 GB 0222787 D0 GB0222787 D0 GB 0222787D0 GB 0222787 A GB0222787 A GB 0222787A GB 0222787 D0 GB0222787 D0 GB 0222787D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inducing compounds
- metastasis inducing
- metastasis
- compounds
- inducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010027476 Metastases Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 230000009401 metastasis Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0222787.4A GB0222787D0 (en) | 2002-10-02 | 2002-10-02 | Metastasis inducing compounds |
AU2003273502A AU2003273502A1 (en) | 2002-10-02 | 2003-10-02 | Metastasis inducing compounds |
PCT/GB2003/004279 WO2004031239A2 (en) | 2002-10-02 | 2003-10-02 | Metastasis inducing compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0222787.4A GB0222787D0 (en) | 2002-10-02 | 2002-10-02 | Metastasis inducing compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0222787D0 true GB0222787D0 (en) | 2002-11-06 |
Family
ID=9945131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0222787.4A Ceased GB0222787D0 (en) | 2002-10-02 | 2002-10-02 | Metastasis inducing compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003273502A1 (en) |
GB (1) | GB0222787D0 (en) |
WO (1) | WO2004031239A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006061418A2 (en) * | 2004-12-09 | 2006-06-15 | Ingenium Pharmaceuticals Ag | Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion |
GB0616929D0 (en) * | 2006-08-26 | 2006-10-04 | Univ Liverpool | Antibodies, assays and hybridomas |
WO2008026009A1 (en) * | 2006-08-29 | 2008-03-06 | Oxford Genome Sciences (Uk) Ltd | Protein |
KR100982186B1 (en) * | 2010-01-21 | 2010-09-14 | 전남대학교산학협력단 | Novel tumor antigen protein agr2 and tumor antigenpeptide thereof |
US9415088B2 (en) | 2011-02-25 | 2016-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Use of AGR3 for treating cancer |
CN102268089A (en) * | 2011-07-05 | 2011-12-07 | 上海交通大学 | AGR2 (Anterior Gradient-2) blocking antibody and application thereof |
US10494676B2 (en) | 2013-12-02 | 2019-12-03 | Albert-Ludwigs-Universitaet Freiburg | Process for the diagnosis of cancer by using exosomes |
WO2017120274A1 (en) * | 2016-01-08 | 2017-07-13 | Temple University Of The Commonwealth System Of Higher Education | Stabilized peptide fragments from protocadherin fat1 as cancer biomarkers |
CN109576229A (en) * | 2018-12-13 | 2019-04-05 | 华中科技大学同济医学院附属协和医院 | A kind of monoclonal antibody hybridoma cell strain and its application for secreting anti-AGR2 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002508652A (en) * | 1996-08-23 | 2002-03-19 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Novel human growth factor |
WO1998041627A1 (en) * | 1997-03-19 | 1998-09-24 | Zymogenetics, Inc. | Secreted polypeptides with homology to xenopus cement gland proteins |
US6528054B1 (en) * | 1998-12-28 | 2003-03-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
GB0004576D0 (en) * | 2000-02-25 | 2000-04-19 | Oxford Glycosciences Uk Ltd | Proteins |
US6974667B2 (en) * | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
GB0023080D0 (en) * | 2000-09-20 | 2000-11-01 | Univ Liverpool | Prognostic indicator |
EP1425302A2 (en) * | 2001-01-24 | 2004-06-09 | Protein Design Labs | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
-
2002
- 2002-10-02 GB GBGB0222787.4A patent/GB0222787D0/en not_active Ceased
-
2003
- 2003-10-02 AU AU2003273502A patent/AU2003273502A1/en not_active Abandoned
- 2003-10-02 WO PCT/GB2003/004279 patent/WO2004031239A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004031239A2 (en) | 2004-04-15 |
WO2004031239A3 (en) | 2004-05-27 |
AU2003273502A8 (en) | 2004-04-23 |
AU2003273502A1 (en) | 2004-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0202216D0 (en) | Novel compounds | |
GB0205256D0 (en) | Novel compounds | |
GB0202679D0 (en) | Novel compounds | |
GB0206723D0 (en) | Novel compounds | |
GB0222516D0 (en) | Novel compounds | |
GB0222787D0 (en) | Metastasis inducing compounds | |
GB0207246D0 (en) | Novel compounds | |
GB0203299D0 (en) | Novel compounds | |
GB0200025D0 (en) | Novel compounds | |
GB0207450D0 (en) | Novel compounds | |
GB0222788D0 (en) | Metastasis inducing compounds | |
GB0212355D0 (en) | Novel compounds | |
GB0204252D0 (en) | Novel compounds | |
GB0205649D0 (en) | Novel compounds | |
GB0203677D0 (en) | Novel compounds | |
GB0203673D0 (en) | Novel compounds | |
GB0201231D0 (en) | Novel compounds | |
GB0201211D0 (en) | Novel compounds | |
GB0200787D0 (en) | Novel compounds | |
GB0200503D0 (en) | Novel compounds | |
GB0200108D0 (en) | Novel compounds | |
GB0204758D0 (en) | Novel compounds | |
GB0204305D0 (en) | Novel compounds | |
GB0202140D0 (en) | Novel compounds | |
GB0204255D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |